AKT1 and triple-A syndrome: These results indicate that CD5L maintains or enhances PI3K/Akt activity, suppresses NF‐κB activation, reduces M1 polarization and pro‐inflammatory cytokine release, and thereby exerts a protective effect in the AAA microenvironment.